VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 186 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,471,804 | +40.6% | 223,295 | +105.9% | 0.00% | +33.3% |
| Q2 2023 | $1,757,426 | -17.1% | 108,432 | -14.9% | 0.00% | -25.0% |
| Q1 2023 | $2,120,955 | +52.6% | 127,371 | -13.9% | 0.00% | +33.3% |
| Q4 2022 | $1,389,800 | +248.3% | 147,904 | +1.0% | 0.00% | +200.0% |
| Q3 2022 | $399,000 | -2.2% | 146,438 | +3.7% | 0.00% | 0.0% |
| Q2 2022 | $408,000 | -56.1% | 141,251 | +29.2% | 0.00% | -50.0% |
| Q1 2022 | $929,000 | +126.6% | 109,364 | +22.7% | 0.00% | +100.0% |
| Q4 2021 | $410,000 | -18.3% | 89,136 | +11.5% | 0.00% | 0.0% |
| Q3 2021 | $502,000 | +7.7% | 79,965 | +2.8% | 0.00% | 0.0% |
| Q2 2021 | $466,000 | +1.7% | 77,765 | +7.3% | 0.00% | 0.0% |
| Q1 2021 | $458,000 | +8.3% | 72,445 | -3.7% | 0.00% | 0.0% |
| Q4 2020 | $423,000 | +0.2% | 75,215 | +4.1% | 0.00% | 0.0% |
| Q3 2020 | $422,000 | -3.9% | 72,285 | +18.7% | 0.00% | 0.0% |
| Q2 2020 | $439,000 | +115.2% | 60,898 | +39.0% | 0.00% | 0.0% |
| Q1 2020 | $204,000 | – | 43,821 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $2,005,000 | 5.90% |
| Sio Capital Management, LLC | 731,453 | $5,866,000 | 1.40% |
| KNOTT DAVID M | 218,102 | $1,749,000 | 0.71% |
| ArrowMark Colorado Holdings LLC | 8,813,578 | $70,685,000 | 0.63% |
| DAFNA Capital Management LLC | 209,200 | $1,678,000 | 0.58% |
| Park West Asset Management LLC | 1,545,075 | $12,391,000 | 0.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 590,000 | $4,732,000 | 0.39% |
| Cornerstone Capital, Inc. | 245,796 | $1,971,000 | 0.28% |
| Ikarian Capital, LLC | 150,000 | $1,203,000 | 0.20% |
| Ikarian Capital, LLC | 150,000 | $1,203,000 | 0.20% |